In relation to breast cancer, stathmin has been associated with aggressive features such as large tumour size15, high histological grade15,16, hormone receptor negativity15–17,20, basal-like and triple negative phenotypes17, as well as reduced survival in some studies18–20,38. Here, NR4A1 is linked to breast cancer.